Friday, January 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Medical Countermeasures

DARPA Supports Research on Pollen for Oral Vaccine Delivery

by Global Biodefense Staff
November 28, 2012

A recipient of the Defense Advanced Research Projects Agency (DARPA) Young Faculty Award is researching a novel method for packaging and delivery of orally consumed vaccines utilizing pollen. 

The exterior of a pollen grain is a shell made of a naturally durable, non-allergenic polymer. The contents of the shell can be cleaned out, eliminating the allergy-inducing materials and providing a neutral ‘suitcase’ to be filled with vaccines. 

Pollen Shells as Vaccine Delivery Carrier
Club moss pollen/spores for oral vaccination. Scanning electron micrographs of (A) intact pollens, (B) interior of manually crushed pollen showing native plant matter, and (C) interior of manually crushed pollen after pollen-cleaning procedure to remove plant biomolecules. (D) Confocal micrograph showing a model test vaccine filled into clean pollen.
Image courtesy of DARPA

Traditional oral tablets encounter obstacles from the body, such as stomach acids, which reduce efficiency in absorption of the medication. The increased durability of the pollen carrier is thought to offer an advantage for better absorption through the intestine. 

“Because pollen shells are durable… they can potentially survive inside the body and safeguard a vaccine until it can be delivered,” states an announcement from DARPA. “All this means that along with the traditional image of pollen as airborne particles that cause headaches and sneezing, pollen could also eventually be known as an edible vaccine delivery vehicle.” 

Oral vaccines provide the benefit of inducing both systemic and mucosal immune responses for enhanced protection. Additionally, such vaccines would be more easily transported and administered to deployed troops or to resource limited environments. 

Read more at DARPA’s official website: Pollen – Can Human’s Seasonal Bane Become a Tool in the Fight Against Disease?

Tags: AwardsDARPAVaccines

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC